By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vitality Biopharma 

1901 Avenue of the Stars, 2nd Floor

Los Angeles  California  90067  U.S.A.
Phone: 530-231-7800 Fax: n/a


Vitality Biopharma has developed a new class of cannabinoid prodrugs, known as cannabosides, which upon ingestion can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Site-specific delivery could enable oral drug formulations of cannabinoids to provide therapeutic benefits while reducing or avoiding the systemic delivery of THC into the bloodstream. Currently, high concentrations of psychoactive THC in the brain limit the dose of cannabinoids that can be used elsewhere in the body for treatment of pain and inflammation.


Founder: Robert Brooke, and Avtar Dhillon

Founder (Scientific): Brandon Zipp, PhD

CEO: Robert Brooke


Key Statistics

Ownership: Private

Web Site: Vitality Biopharma

Company News
Vitality Biopharma To Present At The Moneyshow San Francisco Conference 8/23/2017 8:33:45 AM
Vitality Biopharma Releases Positive Results For Treatment Of Inflammatory Bowel Disease 7/19/2017 8:08:37 AM
Vitality Biopharma Advisor To Present Pediatric IBD Case Study At ICRS2017 In Montreal 6/23/2017 8:13:13 AM
Vitality Biopharma Advisor To Present At 11th National Clinical Conference On Cannabis Therapeutics 5/18/2017 6:41:08 AM
Vitality Biopharma Announces Positive Results For Cannabinoid Antibiotics 5/11/2017 11:56:58 AM
Vitality Biopharma Adds Key Clinical Advisors In Gastroenterology 5/4/2017 12:39:36 PM
Vitality Biopharma Releases Clinical Report Of Cannabinoid Therapy For Pediatric IBD 4/21/2017 12:47:16 PM
Vitality Biopharma Appoints Pharma Industry Veteran To Advance Cannabosides Regulatory Development 4/12/2017 12:19:37 PM
Vitality Biopharma Announces Positive Results For Colon Cancer 3/31/2017 11:31:57 AM
Vitality Biopharma Publishes Scientific Data On Discovery Of Cannabinoid Glycosides 2/1/2017 8:35:39 AM